This content is machine translated Type 2 diabetes Recommendations for the choice of therapy up to date In recent years, the treatment of type 2 diabetes has been expanded to include more and more options. However, this adds to the complexity of therapy selection. So what can…
View Post 4 min This content is machine translated Sponsored Content Semaglutide – a modern GLP-1 analogue in type 2 diabetes People with type 2 diabetes have too little endogenous GLP-1 (glucagon-like peptide 1). Semaglutide, which mimics natural GLP-1, can compensate.1 Like endogenous GLP-1, it normalizes blood glucose, supports weight loss,…
View Post 2 min This content is machine translated Diabetes Cases Diabetes treatment for increased risk to heart and kidney How should a typical diabetic patient, 55-year-old, obese, with hypertension, dyslipidemia, and reduced renal function be treated?
View Post 6 min This content is machine translated Type 2 diabetes Better quality of life thanks to modern diabetes therapy The cardiovascular benefit of SGLT2 inhibitors and GLP1 analogues is now considered established, and non-diabetics may also benefit. For optimal results, therapy should be tailored to individual patient characteristics.
View Post 2 min This content is machine translated Biologics for psoriasis Head-to-head study delivers exciting results Interleukin-23 and interleukin-17A play an important role in the inflammatory process of plaque psoriasis. A comparison of two agents directed against these targets in moderate to severe plaque psoriasis led…
View Post 4 min This content is machine translated Diabetes Cases Prevention of cardiovascular events in type 2 diabetes. Type 2 diabetes mellitus (T2DM) is associated with a greatly increased risk of cardiovascular disease [1]. The joint management of T2DM and the cardiovascular risks has therefore come into focus…
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion Module: COVID-19 and oncology patients There are no evidence-based recommendations for the management of tumor patients in corona crisis. The procedure is based worldwide on rational considerations and analogies. Through careful observations and exchange of… CME-Test
View Post 3 min This content is machine translated Diabetic nephropathy Inhibition of sodium-glucose transporter type 2 has a renoprotective effect Diabetic nephropathy is the most common cause of chronic kidney failure – and one of the most common consequences of diabetes mellitus. The introduction of sodium-glucose transporter type 2 (SGLT2)…
View Post 3 min This content is machine translated Diabetes Cases Multifactorial treatment of type 2 diabetes mellitus A 36-year-old obese patient wants to focus more on therapy for his type 2 diabetes mellitus and weight after his thyroidectomy. He also suffers from hypertension and dyslipidemia, which must…
View Post 4 min This content is machine translated Rheumatoid arthritis New JAK inhibitor raises hopes Treatment with disease-modifying antirheumatic drugs (DMARDs) plays an important role in modern therapeutic concepts for rheumatoid arthritis. If left untreated, joint destruction and loss of mobility are possible consequences of…
View Post 2 min This content is machine translated Editorial Swiss Oncology in Motion: Video-based online training courses Educational films in various modules for medical oncologists, hematologists and oncology specialists. Oncology is on the move – research is advancing rapidly and new insights into biology and therapy are…
